Generate Biomedicines, Inc. (GENB) stock
GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$10.38+0.54 (+5.49%)
Close on Nov 18, 2026Market cap $1.33BP/E –Yield –
Generate Biomedicines shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Generate Biomedicines's shares outstanding was 129M at Sep 30, 2026.
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 129M | +289.5% |
| Q2 FY2026 | Jun 30, 2026 | 128M | +291.1% |
| Q1 FY2026 | Mar 31, 2026 | 65M | – |
| Q3 FY2025 | Sep 30, 2025 | 33M | – |
| Q2 FY2025 | Jun 30, 2025 | 33M | – |
| Q1 FY2025 | Mar 31, 2025 | 33M | – |
See a number that looks wrong?